In summary, these results demonstrated that CD19+CD24hiCD27+ B cells in SF from RA patients were a much more significant source of RANKL than that in RA PB and had a greater propensity to support OC differentiation in a RANKL-dependent manner. Here, CD19 is linked to rheumatoid arthritis.